A RETROspective Study of Patients With TK2d

Clinical trial NCT03701568 · COMPLETED

Trial details

NCT number: NCT03701568
Sponsor: Zogenix MDS, Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Thymidine Kinase 2 (TK2)

Start date: 2018-11-19
Primary completion: 2019-04-30
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.